Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.

Détails

ID Serval
serval:BIB_69180BE3DCEB
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.
Périodique
American journal of physiology. Lung cellular and molecular physiology
Auteur⸱e⸱s
Viget N.B., Guery B.P., Ader F., Nevière R., Alfandari S., Creuzy C., Roussel-Delvallez M., Foucher C., Mason C.M., Beaucaire G., Pittet J.F.
ISSN
1040-0605 (Print)
ISSN-L
1040-0605
Statut éditorial
Publié
Date de publication
12/2000
Peer-reviewed
Oui
Volume
279
Numéro
6
Pages
L1199-209
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
We have previously reported that keratinocyte growth factor (KGF) attenuates alpha-naphthylthiourea-induced lung injury by upregulating alveolar fluid transport. The objective of this study was to determine the effect of KGF pretreatment in Pseudomonas aeruginosa pneumonia. A 5% bovine albumin solution with 1 microCi of (125)I-labeled human albumin was instilled into the air spaces 4 or 24 h after intratracheal instillation of P. aeruginosa, and the concentration of unlabeled and labeled proteins in the distal air spaces over 1 h was used as an index of net alveolar fluid clearance. Alveolocapillary barrier permeability was evaluated with an intravascular injection of 1 microCi of (131)I-albumin. In early pneumonia, KGF increased lung liquid clearance (LLC) compared with that in nonpretreated animals. In late pneumonia, LLC was significantly reduced in the absence of KGF but increased above the control value with KGF. KGF pretreatment increased the number of polymorphonuclear cells recovered in the bronchoalveolar lavage fluid and decreased bacterial pulmonary translocation. In conclusion, KGF restores normal alveolar epithelial fluid transport during the acute phase of P. aeruginosa pneumonia and LLC in early and late pneumonia. Host response is also improved as shown by the increase in the alveolar cellular response and the decrease in pulmonary translocation of bacteria.
Mots-clé
Albumins/pharmacokinetics, Animals, Body Fluids/metabolism, Bronchoalveolar Lavage Fluid/cytology, Bronchoalveolar Lavage Fluid/immunology, Bronchoalveolar Lavage Fluid/microbiology, Disease Models, Animal, Fibroblast Growth Factor 10, Fibroblast Growth Factor 7, Fibroblast Growth Factors, Growth Substances/pharmacology, Iodine Radioisotopes, Macrophages, Alveolar/immunology, Macrophages, Alveolar/microbiology, Pneumonia, Bacterial/drug therapy, Pneumonia, Bacterial/mortality, Pneumonia, Bacterial/pathology, Pseudomonas Infections/drug therapy, Pseudomonas Infections/mortality, Pseudomonas Infections/pathology, Pseudomonas aeruginosa, Pulmonary Alveoli/metabolism, Pulmonary Alveoli/microbiology, Pulmonary Alveoli/pathology, Rats, Rats, Sprague-Dawley, Specific Pathogen-Free Organisms, Survival Rate
Pubmed
Web of science
Création de la notice
29/04/2021 10:59
Dernière modification de la notice
17/07/2023 14:31
Données d'usage